DOI:
10.1055/s-00000045
Der Nuklearmediziner
Issue 02 ·
Volume 38 ·
May 2015
DOI: 10.1055/s-005-29285
Editorial
73
Eiber, M.;
Baum, R. P.:
Prostate carcinoma – Imaging and Therapy in Changing
Diagnostik und Therapie des Prostatakarzinoms – Neue Entwicklungen
75
Weirich, G.:
Pathology of Prostate Cancer
78
Heck, M. M.;
Gschwend, J. E.;
Kübler, H.:
Current Systemic Treatment Options in Patients with Metastatic Prostate Cancer
83
Bartkowiak, D.;
Bottke, D.;
Wiegel, T.:
External-beam Radiotherapy as Primary Treatment Option for Localized Prostate Cancer
89
Weineisen, M.;
Robu, S.;
Schottelius, M.;
Wester, H.-J.:
Novel and Established Radiopharmaceuticals for Diagnosis and Therapy of Prostate Carcinoma
99
Eiber, M.;
Rauscher, I.;
Holzapfel, K.;
Schwaiger, M.;
Maurer, T.:
Imaging of Primary Prostate Cancer: Current Status and New Developments
119
Lohrmann, C.;
Weber, W.:
PET/CT diagnostics of Prostata Cancer using Bombesinanaloga
124
Afshar-Oromieh, A.;
Kratochwil, C.;
Eder, M.;
Eisenhut, M.;
Kopka, K.;
Haberkorn, U.:
Diagnosis of Recurrent Prostate Cancer with PSMA-Ligand PET/CT and Clinical Introduction of PSMA-based Radioligand Therapy
131
138
Pfannkuchen, N.;
Meckel, M.;
Kubicek, V.;
Hermann, P.;
Bergmann, R.;
Steinbach, J.;
Pietzsch, J.;
Bal, C. S.;
Kulkarni, H. R.;
Mohnike, W.;
Baum, R. P.;
Rösch, F.:
68Ga- and 177Lu-labeled Bisphosphonates as Theranostic Agents for Bone Metastases
145
Baum, R. P.;
Kulkarni, H. R.;
Volkmer, B.;
Bohuslavizki, K. H.;
Schuchardt, C.;
Klette, I.;
Singh, A.;
Wester, H.-J.:
Theranostics of Metastatic Prostate Cancer Applying Lu-177 PSMA Small Molecules in Combination with Ga-68 PSMA PET/CT
CME-Fortbildung
109
Heuschkel, M.;
Krause, B. J.;
Hakenberg, O. W.;
Schwarzenböck, S. M.:
Choline PET/CT for Diagnosis, Staging and Restaging of Prostate Cancer
Recht und Wissenschaft
153
The Replacement of the Health Insurance License of Physicians During the Sales of Practice
